Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation

Introduction: The long-term effect of angiotensin II receptor blockers (ARBs) on atrial fibrillation (AF) is unclear. In this study, we evaluated the change in the fibrillation cycle length (FCL) in patients under long-term ARB therapy for chronic AF. Methods and results: The study population consis...

Full description

Bibliographic Details
Main Authors:	Jun Kishihara, Shinichi Niwano, Hiroe Niwano, Yuya Aoyama, Shoko Ishikawa, Jun Oikawa, Akira Sato, Masami Murakami, Michiro Kiryu, Tohru Izumi
Format:	Article
Language:	English
Published:	Wiley 2012-02-01
Series:	Journal of Arrhythmia
Subjects:	Angiotensin II receptor blocker Atrial fibrillation Fibrillation cycle length
Online Access:	http://www.sciencedirect.com/science/article/pii/S1880427612000075

Similar Items

Attenuating Effects of Anti-Arrhythmic Agents on Changes in Fibrillation Cycle Length in Very Early Phase Paroxysmal Atrial Fibrillation —Spectral Analysis of Fibrillation Waves in Surface ECG—
by: Hidehira Fukaya, MD, et al.
Published: (2009-01-01)

Advances in angiotensin-(1-7) and atrial fibrillation
by: Yan-Guang Miao, et al.
Published: (2019-06-01)

Effect of nifekalant on life-threatening ventricular arrhythmias in patients with cardiopulmonary resuscitation or during the perioperative state
by: Shoji Hirasawa, et al.
Published: (2008-01-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
by: Mohamed Zeinah, et al.
Published: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
by: Hebah Hassan, BS, et al.
Published: (2020-06-01)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
by: Akif Arslan, et al.
Published: (2016-01-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
by: Antonio Eduardo Pesaro, et al.
Published: (2010-01-01)

Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
by: Abraham, W.T, et al.
Published: (2022)

Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
by: Teruhiko Imamura, et al.
Published: (2020-10-01)

Ventricular Fibrillation in Patient with Multi-vessel Coronary Spasm Four Days after the Initiation of Oral Beta-blocker
by: Manabu Kurabayashi, et al.
Published: (2016-07-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
by: Tianyu Xu, et al.
Published: (2019-06-01)

Alcohol-induced Ventricular Fibrillation in Brugada Syndrome
by: Takekuni Hayashi, MD, et al.
Published: (2009-01-01)

Morphological Properties of Atrial Fibrillation Waves in Patients with Left Ventricular Dysfunction—Spectral Analysis of Atrial Fibrillation Waves in Dilated Cardiomyopathy—
by: Takeshi Sasaki, MD, et al.
Published: (2006-01-01)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
by: Wenkui Lv, et al.
Published: (2020-11-01)

2. Role of ascorbic acid & statin in reduction of the incidence of the atrial fibrillation in patients under B-blocker and undergoing coronary artery bypass graft operation in early post-operative period
by: Hazem Bakr, et al.
Published: (2015-10-01)

Atrial fibrillation after cardiac surgery
by: Nair Suresh
Published: (2010-01-01)

Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01)

Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation
by: Andreas eGoette, et al.
Published: (2012-07-01)

Paroxysmal atrial fibrillation in 5 months old Afro-Caribbean
by: Sandra Williams-Phillips
Published: (2014-11-01)

Inflammation role in atrial fibrillation pathogenesis
by: A. I. Tarzimanova, et al.
Published: (1970-01-01)

November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
by: Nahapetian RR, et al.
Published: (2015-12-01)

Impact of bisoprolol transdermal patch on early recurrence during the blanking period after atrial fibrillation ablation
by: Yuya Suzuki, et al.
Published: (2021-06-01)

Renin-angiotensin system blockers and COVID-19
by: Emmanuelle Vidal-Petiot, et al.
Published: (2021-06-01)

Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension
by: Min-Hui Jiang, et al.
Published: (2013-11-01)

Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
by: Nakanishi Kazuhiro, et al.
Published: (2013-01-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Usefulness of ST elevation score by using vector-projected virtual 187-channel ECG for risk stratification in patients with Brugada-type ECG pattern
by: Shoko Ishikawa, et al.
Published: (2012-08-01)

Management of hypertension: Insights into prescribing behavior with focus on angiotensin receptor blockers
by: S Ramakrishnan, et al.
Published: (2017-01-01)

Atrial Fibrillation in Wolff-Parkinson-White Syndrome
by: Andy Kieu, DO, et al.
Published: (2019-10-01)

Angiotensin receptor blocker-induced bilateral ciliochoroidal effusion
by: Kanika Aggarwal, et al.
Published: (2020-01-01)

SUGGESTED CONSERVATIVE APPROACH TO PREVENTION OF LATE RECURRENT ATRIAL FIBRILLATION AFTER CATHETER ABLATION (PILOT STUDY)
by: B. A. Tatarsky
Published: (2018-03-01)

Prognosis of patients with coronary vasospasm after successful resuscitation from ventricular fibrillation
by: Akiko Ishihara, MD, et al.
Published: (2012-04-01)

THIOFLAVIN T BINDING TO THE MODEL FIBRILS OF LYSOZYME: THE EFFECTS OF FIBRIL TWISTING
by: A. E. Kokorev, et al.
Published: (2017-12-01)

Pharmacological Therapy for Fibrillations
by: Akira Fujiki, MD
Published: (2007-01-01)

Sudden onset of atrial fibrillation during neck dissection: Vagal atrial fibrillation
by: Anjana Sahu, et al.
Published: (2016-01-01)

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients
by: Hang Zhang, et al.
Published: (2016-01-01)

Role of atrial structural and functional changes in the development and progression of atrial fibrillation
by: O P Aparina, et al.
Published: (2014-01-01)